Lupin reports net profit of Rs 130 crore in Q2 Ruchika Sharma11 Nov 2022 3:30 PM ISTNew Delhi: Drug maker Lupin on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.The...
Lupin to pay Rs 1824 crore to settle diabetes drug Glumetza suit in US Medical Dialogues Team23 Sept 2021 3:41 PM ISTNew Delhi: In an out-of-court settlement, Indian generic drug maker Lupin Pharmaceuticals Inc has decided to pay the Direct Purchaser Group Rs 1,103...
Express Scripts drops coverage of Valeant diabetes drug Glumetza savita thakur thakur1 Feb 2016 9:10 AM ISTNew York: Express Scripts Holding Co, the U.S. No. 1 pharmacy benefits manager, said it would stop covering Glumetza, a diabetes drug made by Valeant...
